Literature DB >> 20595094

TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study.

Mar Mallo, Gemma Osca, Julia Solórzano, Leonor Arenillas, Lourdes Florensa, Francesc Solé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595094      PMCID： PMC2948110          DOI： 10.3324/haematol.2010.027920

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Molecular basis of myelodysplastic/myeloproliferative neoplasms.

Authors:  Andreas Reiter; Rosangela Invernizzi; Nicholas C P Cross; Mario Cazzola
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

2.  Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?

Authors:  F Viguié; A Aboura; D Bouscary; S Ramond; A Delmer; G Tachdjian; J P Marie; N Casadevall
Journal:  Leukemia       Date:  2005-08       Impact factor: 11.528

3.  Small supernumerary marker chromosome causing partial trisomy 6p in a child with craniosynostosis.

Authors:  Olaya Villa; Miguel Del Campo; Marta Salido; Blanca Gener; Laura Astier; Jesús Del Valle; Fátima Gallastegui; Luis A Pérez-Jurado; Francesc Solé
Journal:  Am J Med Genet A       Date:  2007-05-15       Impact factor: 2.802

4.  Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

Authors:  Anna M Jankowska; Hadrian Szpurka; Ramon V Tiu; Hideki Makishima; Manuel Afable; Jungwon Huh; Christine L O'Keefe; Rebecca Ganetzky; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

5.  Acquired mutations in TET2 are common in myelodysplastic syndromes.

Authors:  Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

6.  Mutation in TET2 in myeloid cancers.

Authors:  François Delhommeau; Sabrina Dupont; Véronique Della Valle; Chloé James; Severine Trannoy; Aline Massé; Olivier Kosmider; Jean-Pierre Le Couedic; Fabienne Robert; Antonio Alberdi; Yann Lécluse; Isabelle Plo; François J Dreyfus; Christophe Marzac; Nicole Casadevall; Catherine Lacombe; Serge P Romana; Philippe Dessen; Jean Soulier; Franck Viguié; Michaela Fontenay; William Vainchenker; Olivier A Bernard
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

7.  TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.

Authors:  Olivier Kosmider; Véronique Gelsi-Boyer; Marion Ciudad; Cindy Racoeur; Valérie Jooste; Norbert Vey; Bruno Quesnel; Pierre Fenaux; Jean-Noël Bastie; Odile Beyne-Rauzy; Aspasia Stamatoulas; François Dreyfus; Norbert Ifrah; Stéphane de Botton; William Vainchenker; Oliver A Bernard; Daniel Birnbaum; Michaëla Fontenay; Eric Solary
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.